Nanox gets FDA nod for HealthOST

By staff writers

April 28, 2022 -- Digital x-ray company Nanox’s artificial intelligence (AI) subsidiary Nanox.AI has received U.S. Food and Drug Administration (FDA) 510(k) clearance for HealthOST, an AI-based software application for qualitative and quantitative analysis of CT spine imaging.

HealthOST provides fully automated spinal analysis of vertebral compression fractures and low bone density often associated with osteoporosis to support clinicians in the evaluation and assessment of musculoskeletal disease, according to the vendor.

The FDA clearance is Nanox.AI's 10th across its portfolio of AI clinical-decision assistance tools and its second clearance for vertebral compression fracture detection software, Nanox said.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking